[ad_1]
TThe news reads like Heritage Foundation fan fiction. Pfizer, a 171-year-old paragon of American industry, was the first to generate truly promising data on a Covid-19 vaccine. And like a pharmaceutical John Henry – or John Galt – the company did it without accepting a single dollar from the federal government and its Operation Warp Speed.
Major drugmakers have spent years arguing that their often controversial pricing practices are the essential trade-off for drugs that sometimes change the world. And here is Pfizer, using only its vast profits to achieve “possibly the most important medical breakthrough in the last 100 years”, as his CEO introduced him to CNBC.
Unlock this article by subscribing to STAT + and enjoy your first 30 days free!
TO START
What is that?
STAT + is STAT’s premium subscription service for in-depth coverage and analysis in biotechnology, pharmacy, policy, and life sciences. Our award-winning team covers Wall Street news, political developments in Washington, early scientific breakthroughs and clinical trial results, and the disruption of healthcare in Silicon Valley and beyond.
What’s included?
- Daily reports and analyzes
- Industry’s most comprehensive coverage by a team of powerful journalists
- Subscriber-only newsletters
- Daily newsletters to keep you informed about the most important news in the sector
- STAT + conversations
- Weekly opportunities to engage with our reporters and leading industry experts in live video chats
- Exclusive industry events
- Premium access to subscriber-only networking events nationwide
- The best reporters in the industry
- The most reliable and most connected newsroom in the healthcare industry
- And much more
- Exclusive interviews with industry leaders, profiles and high-end tools, like our CRISPR Trackr.
[ad_2]
Source link